Chan‐Loi Yong
- Hepatology top 2%
- Epidemiology top 10%
- Infectious Diseases top 5%
- Molecular Biology
- Virology top 5%
- Co-authors
- Gerhard SteinmannYves BenhamouGerhard NehmizHeiner WedemeyerHolger HinrichsenMarkus ReiserJosé Luís CallejaAndreas Erhardt
- Topics
- HIV/AIDS drug development and treatment (11 papers)Hepatitis C virus research (7 papers)HIV Research and Treatment (5 papers)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Chan‐Loi Yong
22 papers receiving 895 citations
Peers
Comparison fields: 5 of 99
- Hepatology 432
- Epidemiology 400
- Infectious Diseases 260
- Molecular Biology 162
- Virology 101
Countries citing papers authored by Chan‐Loi Yong
This map shows the geographic impact of Chan‐Loi Yong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chan‐Loi Yong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chan‐Loi Yong more than expected).
Fields of papers citing papers by Chan‐Loi Yong
This network shows the impact of papers produced by Chan‐Loi Yong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chan‐Loi Yong. The network helps show where Chan‐Loi Yong may publish in the future.
Co-authorship network of co-authors of Chan‐Loi Yong
This figure shows the co-authorship network connecting the top 25 collaborators of Chan‐Loi Yong. A scholar is included among the top collaborators of Chan‐Loi Yong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chan‐Loi Yong. Chan‐Loi Yong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 5 | |
| 3 | 8 | |
| 4 | 4 | |
| 5 | 13 | |
| 6 | 8 | |
| 7 | 89 | |
| 8 | 46 | |
| 9 | 22 | |
| 10 | 13 | |
| 11 | Virological response and safety of BI 201335 protease inhibitor, peginterferon alfa 2a and ribavirin treatment of HCV genotype-1 patients with compensated liver cirrhosis and non-response to previous peginterferon/ribavirin | 1 |
| 12 | 121 | |
| 13 | 233 | |
| 14 | 13 | |
| 15 | 2 | |
| 16 | 203 | |
| 17 | 5 | |
| 18 | 49 | |
| 19 | 32 | |
| 20 | 17 |
About Chan‐Loi Yong
Chan‐Loi Yong is a scholar working on Virology, Hepatology and Infectious Diseases, having authored 22 papers that have together received 944 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (11 papers), Hepatitis C virus research (7 papers) and HIV Research and Treatment (5 papers). The work is most often cited by research in Hepatology (432 citations), Virology (101 citations) and Infectious Diseases (260 citations). Chan‐Loi Yong has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Gerhard Steinmann, Yves Benhamou, Gerhard Nehmiz, Heiner Wedemeyer, Holger Hinrichsen, Markus Reiser, José Luís Calleja, Andreas Erhardt, Ricardo L. Chaves and Xavier Forns. Their work appears in journals such as The Journal of Immunology, Gastroenterology and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.